These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 9802408

  • 1. Plasma neuropeptide Y of children with neuroblastoma in relation to stage, age and prognosis, and tissue neuropeptide Y.
    Dötsch J, Christiansen H, Hänze J, Lampert F, Rascher W.
    Regul Pept; 1998 Sep 25; 75-76():185-90. PubMed ID: 9802408
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptide Y in neuroblastoma: increased concentration in metastasis, release during surgery, and characterization of plasma and tumor extracts.
    Kogner P, Björk O, Theodorsson E.
    Med Pediatr Oncol; 1993 Sep 25; 21(5):317-22. PubMed ID: 8492745
    [Abstract] [Full Text] [Related]

  • 3. Serial measurements of neuropeptide Y in plasma for monitoring neuroblastoma in children.
    Rascher W, Kremens B, Wagner S, Feth F, Hunneman DH, Lang RE.
    J Pediatr; 1993 Jun 25; 122(6):914-6. PubMed ID: 8501569
    [Abstract] [Full Text] [Related]

  • 4. Neuropeptide Y as a plasma marker for phaeochromocytoma, ganglioneuroblastoma and neuroblastoma.
    Mouri T, Sone M, Takahashi K, Itoi K, Totsune K, Hayashi Y, Hasegawa S, Ohneda M, Murakami O, Miura Y.
    Clin Sci (Lond); 1992 Aug 25; 83(2):205-11. PubMed ID: 1327637
    [Abstract] [Full Text] [Related]

  • 5. Significance of plasma neuropeptide Y (NPY) in diagnosis and prognosis of neuroblastoma.
    Hayashi Y, Ohi R, Sone M, Takahashi K, Mouri T, Watanabe T, Yaoita S, Nakamura M.
    Prog Clin Biol Res; 1991 Aug 25; 366():359-65. PubMed ID: 2068151
    [No Abstract] [Full Text] [Related]

  • 6. Plasma neuropeptide Y concentrations in patients with neuroendocrine tumors.
    Grouzmann E, Comoy E, Bohuon C.
    J Clin Endocrinol Metab; 1989 Apr 25; 68(4):808-13. PubMed ID: 2466046
    [Abstract] [Full Text] [Related]

  • 7. Neuropeptide Y expression in the developing adrenal gland and in childhood neuroblastoma tumors.
    Cohen PS, Cooper MJ, Helman LJ, Thiele CJ, Seeger RC, Israel MA.
    Cancer Res; 1990 Sep 15; 50(18):6055-61. PubMed ID: 2393870
    [Abstract] [Full Text] [Related]

  • 8. Plasma neuropeptide Y (NPY): a novel marker of neuroblastoma.
    Kogner P, Theodorsson E, Björk O.
    Prog Clin Biol Res; 1991 Sep 15; 366():367-73. PubMed ID: 2068152
    [No Abstract] [Full Text] [Related]

  • 9. Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.
    Galli S, Naranjo A, Van Ryn C, Tilan JU, Trinh E, Yang C, Tsuei J, Hong SH, Wang H, Izycka-Swieszewska E, Lee YC, Rodriguez OC, Albanese C, Kitlinska J.
    Am J Pathol; 2016 Nov 15; 186(11):3040-3053. PubMed ID: 27743558
    [Abstract] [Full Text] [Related]

  • 10. Neuropeptide Y as a marker in pediatric neuroblastoma.
    Kogner P, Björk O, Theodorsson E.
    Pediatr Pathol; 1990 Nov 15; 10(1-2):207-16. PubMed ID: 2315229
    [Abstract] [Full Text] [Related]

  • 11. Elevated plasma concentrations of neuropeptide Y in children and adults with chronic and terminal renal failure.
    Bald M, Gerigk M, Rascher W.
    Am J Kidney Dis; 1997 Jul 15; 30(1):23-7. PubMed ID: 9214397
    [Abstract] [Full Text] [Related]

  • 12. Neuropeptide Y (NPY) synthesis in lymphoblasts and increased plasma NPY in pediatric B-cell precursor leukemia.
    Kogner P, Ericsson A, Barbany G, Persson H, Theodorsson E, Björk O.
    Blood; 1992 Sep 01; 80(5):1324-9. PubMed ID: 1387563
    [Abstract] [Full Text] [Related]

  • 13. Expression and precursor processing of neuropeptide Y in human pheochromocytoma and neuroblastoma tumors.
    O'Hare MM, Schwartz TW.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):7010-4. PubMed ID: 2582442
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.
    Farrelly LA, Savage NT, O'Callaghan C, Toulouse A, Yilmazer-Hanke DM.
    Regul Pept; 2013 Sep 10; 186():123-30. PubMed ID: 23994577
    [Abstract] [Full Text] [Related]

  • 15. Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours.
    Bjellerup P, Theodorsson E, Jörnvall H, Kogner P.
    Br J Cancer; 2000 Jul 10; 83(2):171-6. PubMed ID: 10901366
    [Abstract] [Full Text] [Related]

  • 16. Gene expression of neuronal nitric oxide synthase and adrenomedullin in human neuroblastoma using real-time PCR.
    Dötsch J, Harmjanz A, Christiansen H, Hänze J, Lampert F, Rascher W.
    Int J Cancer; 2000 Oct 15; 88(2):172-5. PubMed ID: 11004664
    [Abstract] [Full Text] [Related]

  • 17. Differential neuropeptide Y gene expression in post-mitotic versus dividing neuroblastoma cells driven by an adeno-associated virus vector.
    Wu P, Ziska D, Bonell MA, Grouzmann E, Millard WJ, Meyer EM.
    Brain Res Mol Brain Res; 1994 Jul 15; 24(1-4):27-33. PubMed ID: 7968366
    [Abstract] [Full Text] [Related]

  • 18. Cholinergic muscarinic mechanisms regulate neuropeptide Y gene expression via protein kinase C in human neuroblastoma cells.
    Magni P, Maggi R, Pimpinelli F, Motta M.
    Brain Res; 1998 Jul 06; 798(1-2):75-82. PubMed ID: 9666082
    [Abstract] [Full Text] [Related]

  • 19. Lower plasma neuropeptide Y level in patients with atypical febrile convulsions.
    Lin LC, Lee WT, Chen IJ, Yang RC.
    Kaohsiung J Med Sci; 2010 Jan 06; 26(1):8-12. PubMed ID: 20040467
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors.
    Kitlinska J, Abe K, Kuo L, Pons J, Yu M, Li L, Tilan J, Everhart L, Lee EW, Zukowska Z, Toretsky JA.
    Cancer Res; 2005 Mar 01; 65(5):1719-28. PubMed ID: 15753367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.